|
Re: The problem...as I see it
|
14
|
Resverlogix Corp.
|
Oct 17, 2020 05:32PM
|
|
Re: The problem...as I see it
|
12
|
Resverlogix Corp.
|
Oct 17, 2020 12:20AM
|
|
ORI
|
11
|
Resverlogix Corp.
|
Oct 15, 2020 06:44PM
|
|
Re: Leading From Behind
|
5
|
Resverlogix Corp.
|
Oct 14, 2020 01:04PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
2
|
Resverlogix Corp.
|
Oct 14, 2020 11:07AM
|
|
Re: December 22, 2020.wideout
|
10
|
Resverlogix Corp.
|
Oct 10, 2020 03:22PM
|
|
Re: Resverlogix Announces $13 Million Private Placement
|
9
|
Resverlogix Corp.
|
Oct 07, 2020 12:40PM
|
|
Re: Resverlogix Announces $13 Million Private Placement
|
5
|
Resverlogix Corp.
|
Oct 06, 2020 03:51PM
|
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
8
|
Resverlogix Corp.
|
Oct 04, 2020 01:18PM
|
|
Re: Monday
|
14
|
Resverlogix Corp.
|
Oct 01, 2020 07:33PM
|
|
For the sake of the argument...
|
5
|
Resverlogix Corp.
|
Sep 27, 2020 10:48PM
|
|
Re: SF
|
4
|
Resverlogix Corp.
|
Sep 17, 2020 01:57PM
|
|
Re: Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews
|
3
|
Resverlogix Corp.
|
Sep 15, 2020 09:22AM
|
|
And 10% up again
|
3
|
Resverlogix Corp.
|
Aug 06, 2020 09:49PM
|
|
Hepa...
|
6
|
Resverlogix Corp.
|
Aug 05, 2020 10:32PM
|
|
Re: Eastern Capital - Expiration of warrants
|
2
|
Resverlogix Corp.
|
Jul 23, 2020 06:31PM
|
|
Re: Constellation Pharma
|
14
|
Resverlogix Corp.
|
Jun 30, 2020 01:33PM
|
|
Hepa
|
1
|
Resverlogix Corp.
|
Jun 23, 2020 11:00PM
|
|
FDA meeting confirmed
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 11:19AM
|
|
Re: Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
|
3
|
Resverlogix Corp.
|
Jun 09, 2020 09:13PM
|
